Myxedema coma pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 95: Line 95:
Anemia
Anemia
===Algorythym===
===Algorythym===
{{familytree/start}}<nowiki>{{familytree | | | | | | | | | A01 | | | | | |A01=Hypothyroidism}}
{{familytree | | | | | | | | | |!| | | | | | | | }}
{{familytree | | | | | | | | | B01 | | | | | |B01=Precipitating Factor}}
{{familytree | | | | | | | | | |!| | | | | | | | }}
{{familytree | | | | | | | | | Z01 | | | | | |Z01= '''↓'''T4}}
{{familytree | | | | | | | | | |!| | | | | | | | }}
{{familytree | | | | | | | | | X01 | | | | | |X01=↓ Intracellular T3}}
{{familytree | | |,|-|-|-|v|-|-|^|-|-|v|-|-|-|.| }}
{{familytree | | C01 | | C02 | | | | C03 | | C04 |C01=Hypothalamus|C02=Respiratory|C03=Cardiovascluar|C04=Renal}}
{{familytree | | |!| | | |!| | | | | |!| | | |!| }}
{{familytree | | D01 | | D02 | | | | D03 | | D04 |D01=↓ thermogenesis|D02=Hypercapnia<br>Hypoxia|D03=↓ inotropic <br> bradycardia|D04=↓ Volume status}}
{{familytree | | |!| | | |!| | | | | |!| | | |!| }}
{{familytree | | D01 | | D02 | | | | D03 | | D04 |D01=Hypothermia|D02=Hypoventilation|D03=↓ Cardiac output<br>↓ blood volume|D04=↓ GFR <br>↑ ADH}}
{{familytree | | |!| | | |!| | | | | |!| | | |!| }}
{{familytree | | D01 | | D02 | | | | D03 | | D04 |D01=Alteration of mental state|D02=Cerebral anoxia|D03=↓arterial pressure/shock|D04=Hyponatremia<br> Edema}}
{{familytree | | |!| | | |!| | | | | |!| | | |!| }}
{{familytree | | |`|-|-|-|^|-|-|v|-|-|^|-|-|-|'| }}
{{familytree | | | | | | | | | |!| | | | | | | | }}
{{familytree | | | | | | | | | E01 | | | | | | |E01=Myxedema Coma }}
{{familytree/end}}


==Associated Conditions==
==Associated Conditions==

Revision as of 23:47, 9 October 2017

Myxedema coma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Myxedema coma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myxedema coma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myxedema coma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myxedema coma pathophysiology

CDC on Myxedema coma pathophysiology

Myxedema coma pathophysiology in the news

Blogs on Myxedema coma pathophysiology

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Myxedema coma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Pathophysiology

  • Myxedema coma occurs as a result of long-standing, undiagnosed, or undertreated hypothyroidism.
  • Myxedema coma is usually precipitated by a systemic illness.

Triggers

  • Myxedema coma can result from any of the causes of hypothyroidism, most commonly chronic autoimmune thyroiditis.
  • Myxedema coma can also occur in patients who had thyroidectomy or underwent radioactive iodine therapy for hyperthyroidism.
  • Rare causes may include secondary hypothyroidism and medications such as lithium and amiodarone.

Pathogenesis

  • Thyroid hormone plays an important role in cell metabolism.
  • Long-standing hypothyroidism is associated with reduced metabolic rate and decreased oxygen consumption, which affects all body systems. [5]
  • Reduced metabolism results in hypothermia.
  • Reduced metabolism and decreased oxygen also results in decreased drug metabolism leading to overdosing of medications particularly sedatives, hypnotics, and anesthetic agents; this can precipitate myxedema coma.

The following table summarizes the various effects of reduced thyroid hormone on different organ systems

Organ System Effect due to Decreased Thyroid Hormone Manifestation Cardiovascular Cardiac contractility is impaired Leading to reduced stroke volume

Low cardiac output

Bradycardia

Sometimes hypotension

Reduced stroke volume in severe cases may also be due to pericardial effusions

caused by the accumulation of fluid rich in mucopolysaccharides within the pericardial sac

Hypotension Narrowed pulse pressure

Fluid accumulation in tissue

Pericardial effusions.

Neurologic Altered brain function due to Reduced oxygen delivery and consumption

Decreased glucose utilization

Reduced cerebral blood flow.

Altered consciousness Pulmonary Central depression of ventilatory drive Decreased responsiveness to hypoxia and hypercapnia

Hypoventilation Renal Reduced glomerular filtration rate because of

Low cardiac output

Peripheral vasoconstriction

Rhabdomyolysis

Electrolyte abnormalities

Low volume stimulates

Antidiuretic hormone impairs water excretion leading to hyponatremia

Gastrointestinal mucopolysaccharide infiltration and edema malabsorption

gastric atony

impaired peristalsis,

paralytic ileus

megacolon.

GI bleeding Ascites

Constipation

Hematologic Coagulopathy due to decrease in production of factors V, VII, VIII, IX, and X

Hemorrhage and vitamin B12 deficiency

Bleeding Anemia

Algorythym

Associated Conditions

Gross Pathology

Microscopic Pathology

References